Stock Events

Stock Events

Active Biotech AB 

€0.5800
0
+€0.01+1.31% Friday 06:02

Statistics

Day High
0.58
Day Low
0.58
52W High
0.6743
52W Low
0.469
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20AugExpected
Q1 2022
Next
-0.21
0.12
0.45
0.79
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BTP.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap28.84B
Biogen Inc. focuses on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases, overlapping with Active Biotech's focus on neurodegenerative diseases.
Novartis
NVS
Mkt Cap284.61B
Novartis AG engages in the research, development, and marketing of healthcare products, including treatments for neurological conditions similar to those targeted by Active Biotech.
Roche
RHHBY
Mkt Cap331.58B
Roche Holding AG specializes in pharmaceuticals and diagnostics in multiple sclerosis and cancer, directly competing with Active Biotech's research areas.
Gilead Sciences
GILD
Mkt Cap160.36B
Gilead Sciences, Inc. develops medicines for infectious diseases, liver diseases, cancer, and inflammatory and respiratory diseases, overlapping with Active Biotech's therapeutic areas.
AMGEN
AMGN
Mkt Cap188.67B
Amgen Inc. focuses on human therapeutics, including treatments for illnesses that Active Biotech also targets, such as cancer and inflammatory diseases.
Astrazeneca
AZN
Mkt Cap288.38B
AstraZeneca PLC works on developing products for major disease areas including cancer, which is a key research area for Active Biotech.
Merck
MRK
Mkt Cap298.33B
Merck & Co., Inc. provides healthcare solutions and is involved in the development of pharmaceutical products, including for conditions like cancer, competing with Active Biotech.
Pfizer
PFE
Mkt Cap148.41B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines for oncology, a field Active Biotech is involved in.
Regeneron Pharmaceuticals
REGN
Mkt Cap66.62B
Regeneron Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for serious medical conditions, competing in similar therapeutic areas as Active Biotech.

About

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
Show more...
CEO
ISIN
SE0029278555
WKN
000A41Z2Z

Listings

STU
DE
BTP.STU
F
DE
BTP.F
ST
SE
ACTI.ST
LSE
GB
0GQU.LSE

0 Comments

Share your thoughts

FAQ

What is Active Biotech AB stock price today?▼
The current price of BTP.F is €0.58 EUR — it has increased by +1.31% in the past 24 hours. Watch Active Biotech AB stock price performance more closely on the chart.
What is Active Biotech AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Active Biotech AB stocks are traded under the ticker BTP.F.
When is the next Active Biotech AB earnings date?▼
Active Biotech AB is going to release the next earnings report on August 20, 2026.
What were Active Biotech AB earnings last quarter?▼
BTP.F earnings for the last quarter are -0.21 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Active Biotech AB located?▼
Active Biotech AB operates in the Other sector.
When did Active Biotech AB complete a stock split?▼
The last stock split for Active Biotech AB was on June 03, 2026 with a ratio of 1:100.